Solene Guilliot
Chief Medical Officer ; Head of R&D at Medesis Pharma | Montpellier, Occitanie, France
Solene Guilliot’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Chief Medical Officer ; Head of R&D at Medesis Pharma in May 2021 - Present
Worldwide Scientific Communication & Markets Manager - Canada Lead ; Major Markets Ozanimod Lead at Bristol Myers Squibb in April 2020 - May 2021
Medical Communication Manager at Bristol-Myers Squibb in February 2018 - April 2020
Université Paul Sabatier (Toulouse III), Doctor in Pharmacy - Docteur en Pharmacie, January 2009 to January 2015
Université Victor Segalen (Bordeaux II), Master's degree, January 2014 to January 2015
Lycée Toulouse-Lautrec, Baccalauréat Scientifique Mention Bien, January 2006 to January 2009
A RADICAL CHANGE IN THE WAY DRUGS ARE DELIVERED TO TARGETS Medesis Pharma has developed a revolutionary technology providing a paradigm shift in drug delivery methodology concentrating not just on improving a drugs absorption characteristics, but also by ensuring that a drug reaches its site of action in the most efficient way possible. TROJAN HORSE DELIVERY The human body uses a variety of physiological cellular delivery mechanisms to deliver molecules essential to the workings of every cell. The Aonys® drug delivery technology is able to use these natural mechanisms to circumvent the natural barriers which drugs must overcome to reach reach their sites of action. Research Medesis is undertaking an extensive research program applying the Aonys® technology to a variety of advanced therapeutics which up to now do not have suitable delivery solutions including: - Therapeutic peptides - Antisense oligonucleotides - Heavy metal chelating agents Development Clinical development programs are ongoing for two Aonys® formulated products for the following major indications: Metabolic anomalies linked to insulin resistance (pre-diabetes) Neurodegeneration in Huntington's disease
Discover more about Medesis PharmaPharmD, M2 IS-Conception et Optimisation des Produits de Santé
Interne en Pharmacie at Hôpital Charles Nicolle
(December 2023 – Present)
PhD student
PHD Student at Medesis Pharma
(July 2023 – Present)
Chargée du développement galénique - Medesis Pharma
Chargée du développement galénique at Medesis Pharma
(December 2022 – Present)
Chargée de développement galénique chez Medesis Pharma
Chargé de développement galénique junior at Medesis Pharma
(September 2020 – Present)
Head of project at Medesis Pharma
Head of project at Medesis Pharma
(May 2005 – Present)
Responsable administratif chez Medesis Pharma Inc
Responsable gestion administrative at Medesis Pharma Inc
(November 2014 – Present)
What is Solene Guilliot email address?
Email Solene Guilliot at [email protected] and [email protected]. This email is the most updated Solene Guilliot's email found in 2026.
How to contact Solene Guilliot?
To contact Solene Guilliot send an email to [email protected] or [email protected].
What company does Solene Guilliot work for?
Solene Guilliot works for Medesis Pharma.
What is Solene Guilliot's role at Medesis Pharma?
Solene Guilliot is Chief Medical Officer ; Head of R&D
What industry does Solene Guilliot work in?
Solene Guilliot works in the Pharmaceuticals industry.